Intensive Care Anxiety in SARS-CoV-2 Patients

NCT ID: NCT04715477

Last Updated: 2021-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-17

Study Completion Date

2021-04-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid long-term mental health problems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hospital Anxiety Depression Measure

Hospital Anxiety Depression Measure

Hospital Anxiety Depression Measure

Intervention Type BEHAVIORAL

Hospital Anxiety Depression Measure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hospital Anxiety Depression Measure

Hospital Anxiety Depression Measure

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Above 18 years old
* COVID PCR +,
* admitted to intensive care,
* conscious, cooperative patients

Exclusion Criteria

* Having hearing and speaking problems,
* Can't speak Turkish or English,
* who do not have the cognitive level to understand and answer the questions,
* Communication problems such as dementia and Alzheimer's,
* patients receiving sedation
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Derince Training and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

İLKE KÜPELİ

assoc. prof.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ilke kupeli

Role: PRINCIPAL_INVESTIGATOR

Derince Training and Research Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

İlke Küpeli

İzmit, Kocaeli̇, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

ilke kupeli

Role: CONTACT

05555485632

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

İLKE KÜPELİ

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Deng J, Zhou F, Hou W, Silver Z, Wong CY, Chang O, Huang E, Zuo QK. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021 Feb;1486(1):90-111. doi: 10.1111/nyas.14506. Epub 2020 Oct 2.

Reference Type RESULT
PMID: 33009668 (View on PubMed)

Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020 Jul;7(7):611-627. doi: 10.1016/S2215-0366(20)30203-0. Epub 2020 May 18.

Reference Type RESULT
PMID: 32437679 (View on PubMed)

3. Aydemir Ö, Güvenir T, Küey L, Kültür S. Hastane Anksiyete ve Depresyon Ölçeği Türkçe Formunun Geçerlik Güvenilirlik Çalışması. Türk Psikiyatri Dergisi 1997;8:280-287.

Reference Type RESULT

Kupeli I, Kara MY, Yakin I, Caglayan AC. Anxiety and depression in the first 24 h in COVID-19 patients who underwent non-invasive mechanical ventilation in the intensive care unit. Ir J Med Sci. 2022 Oct;191(5):2291-2295. doi: 10.1007/s11845-021-02808-8. Epub 2021 Oct 19.

Reference Type DERIVED
PMID: 34664224 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

derince TRH 2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.